PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma
Yael Babichev(Mount Sinai Hospital), Rebecca A. Gladdy(Princess Margaret Cancer Centre)
Cited by 53
Related Papers
Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group
|Annals of Surgical Oncology|2021|243
Preoperative Radiotherapy in Patients With Primary Retroperitoneal Sarcoma
|Annals of Surgery|2022|138
Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival
|Nature Communications|2021|64
Has the Outcome for Patients Who Undergo Resection of Primary Retroperitoneal Sarcoma Changed Over Time? A Study of Time Trends During the Past 15 years
|Annals of Surgical Oncology|2020|56
Longitudinal prognostication in retroperitoneal sarcoma survivors: Development and external validation of two dynamic nomograms
|European Journal of Cancer|2021|32